{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:26:30Z","timestamp":1787761590858,"version":"build-2784847793"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Mycobacterium kansasii<\/jats:italic>\n                      is the second most common cause of nontuberculous mycobacterial (NTM) lung disease after\n                      <jats:italic toggle=\"yes\">Mycobacterium avium<\/jats:italic>\n                      complex infection in the United States.\n                      <jats:sup>[1]<\/jats:sup>\n                      The first-line therapy for\n                      <jats:italic toggle=\"yes\">M. kansasii<\/jats:italic>\n                      is a three-drug regimen including rifampin, isoniazid, and ethambutol. We present a case of a patient with pulmonary\n                      <jats:italic toggle=\"yes\">M. kansasii<\/jats:italic>\n                      who developed bullous skin lesions while receiving this regimen and again after rechallenge with ethambutol. In patients with intolerance to one of the first-line antibiotics, a multidisciplinary team approach to starting second-line agents is needed. Ethambutol should be included in the differential diagnosis of drug-induced bullous skin lesions in treated patients with NTM, who develop new onset rash with blisters or ulceration.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_204_21","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T09:02:00Z","timestamp":1682067720000},"page":"120-122","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Ethambutol-Induced Bullous Skin Lesions in Mycobacterium kansasii Lung Infection"],"prefix":"10.4103","volume":"11","author":[{"given":"Venkateswara K.","family":"Kollipara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Lantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Nagy-Agren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20240902","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"R2-19-20240902","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/ijmy.ijmy_141_21","article-title":"Nontuberculous mycobacterium: An emerging pathogen: Indian perspective","volume":"10","author":"Rajendran","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R3-19-20240902","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/2013.jamadermatol.376","article-title":"The associations between bullous pemphigoid and drug use: A UK case-control study","volume":"149","author":"Lloyd-Lavery","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R4-19-20240902","first-page":"1","article-title":"Drug-induced pemphigus diseases","volume":"175","author":"Civatte","year":"1989","journal-title":"Dermatol Monatsschr"},{"key":"R5-19-20240902","first-page":"93","article-title":"Drug-induced pemphigus","volume":"163","author":"Brenner","year":"1998","journal-title":"Clinics in Dermatology"},{"key":"R6-19-20240902","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1073\/pnas.92.11.5239","article-title":"Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: A model for autoimmunity","volume":"92","author":"Bhol","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-19-20240902","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1309\/3CAKPEU8JXGWLEDC","article-title":"Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows prediction of outcome","volume":"130","author":"Maruani","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"R8-19-20240902","first-page":"4412","article-title":"Ethambutol induced bullous and lichenoid skin eruptions","volume":"38","author":"Akrout","year":"2011","journal-title":"Eur Res J"},{"key":"R9-19-20240902","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/archinte.1981.00340130115027","article-title":"Ethambutol-induced toxic epidermal necrolysis","volume":"141","author":"Pegram","year":"1981","journal-title":"Arch Intern Med"},{"key":"R10-19-20240902","doi-asserted-by":"crossref","first-page":"208797","DOI":"10.1155\/2013\/208797","article-title":"Hypersensitivity reaction and tolerance induction to ethambutol","volume":"2013","author":"Cernadas","year":"2013","journal-title":"Case Rep Med"},{"key":"R11-19-20240902","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0378-6323.41393","article-title":"Ashy dermatosis-like pigmentation due to ethambutol","volume":"74","author":"Srivastava","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_204_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:02:19Z","timestamp":1787760139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_204_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_204_21","relation":{},"ISSN":["2212-5531"],"issn-type":[{"value":"2212-5531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}